The course of Nocardia infection may range in severity (from asymptomatic to acute and chronic) and presentation of patients may vary widely, correlating to the affected organs.

It is important to obtain history data about any chronic rheumatologic diseases that could require immunosuppressive therapy and data about any immunosuppressive disease. It is important because nocardiosis is opportunistic and infects mostly immunocompromised patients [1].

Pulmonary nocardiosis is the most common type of nocardiosis [2] and is characterized by non-specific manifestations such as fever, fatigue and weight loss. Specific findings include productive or a non-productive cough, abscess in lungs, empyema, cavitations, bronchiectasis, pleural effusion, and pneumonia [3]. Symptoms like chest pain, shortness of breath can indicate a chronic condition. An infectious mass in the lungs is prone to dissemination. Dissemination occurs locally to the pericardium, pleura, vena cava, and mediastinum. Systematic dissemination could be the cause of abscess formation in other organs, usually extremities [3].

Extrapulmonary nocardiosis most commonly affects cerebral tissue by forming multiple or solitary deep abscesses. These lesions compress the lobes and are held accountable for neurologic manifestations such as headaches, seizures, and altered mental state [4] [5]. Meningitis and non-specific symptoms such as nausea and vomiting can also be present. These signs and symptoms may evolve gradually or acutely, depending on size and location of the abscess. Extrapulmonary manifestations, although mostly involve the cerebrum (44%) [3], can manifest in any organ, especially in the extremities. Infection in such locations arises due to hematogenous dissemination [3].

Primary cutaneous infection occurs from direct inoculation of Nocardia spp. spores and is prevalent in patients who are not immunocompromised. Patients present with purulent inflammation of dermis that is able to ascend to regional lymph nodes (lymphocutaneous infection) or form local abscesses. These masses are typically in lower extremities in adults and on the face in children [4].

Mycetoma is a characteristic chronic state of primary cutaneous infection. It is characterized by purulent fistulas of many colors and sizes as well as granulomas and nodules that are painless and affect subcutis as well as other soft tissues and bone [3]. Superficial cutaneous infection, on the other hand, manifests with all signs of inflammation like pain, warmth, swelling and erythema. Lymphocutanious lesions originate from primary purulent ulcerations allowing the noxious organism to penetrate deeply in affected areas [4].

Secondary cutaneous infection can arise from dissemination in primary pulmonary infection. This manifestation is relatively common [3].

The most important workup findings in nocardiosis infection are those of microbiology and radiology.

If pulmonary nocardiosis is suspected, a chest X-ray or computed tomography (CT) is usually performed. Discovery of solitary or multifocal lesions is typically made. The lesions can be either nodular or of an infiltrative kind, cavitations and pleural effusions can also be identified [6] [7]. Nevertheless, radiography is non-specific and no radiologic signs point specifically to nocardiosis.

An imaging study of central nervous system (CNS) should be performed for patients suffering from severe nocardiosis. Particularly pulmonary nocardiosis and suspected systemic infection or if neurologic symptoms are present, imaging is of vital significance. Magnetic resonance imaging (MRI) is the investigation of choice for such cases [8]. Abscesses either solitary or multiple can be found in different lobes of the cerebrum, perifocal edema usually is also present. The radiologic picture is frequently misdiagnosed as malignancies, vasculitis, or stroke [8]. To avoid misdiagnosis it is necessary to confirm nocardiosis with a microbiologic evaluation.

Depending on the affected site different types of specimens should be collected. A specimen of sputum or bronchial washing in pulmonary nocardiosis, cerebrospinal fluid (CSF) in suspected meningitis, skin biopsy or aspiration from abscess masses in cutaneous nocardiosis. It is necessary to inform laboratories about possible Nocardia infection as haste and slow growth of Nocardia may be the cause of altered results. Nocardia spp. stains with modified acid-fast and Gram stain with cultures being generally isolated in 3-5 days [4].

Treatment of nocardiosis typically involves long-term antibiotic therapy. The most commonly used antibiotic is trimethoprim-sulfamethoxazole (TMP-SMX), but other antibiotics may be used depending on the specific strain of Nocardia and the patient's response to treatment. The duration of therapy can range from several months to a year, depending on the severity and location of the infection.

The prognosis for nocardiosis varies based on several factors, including the patient's overall health, the extent of the infection, and how quickly treatment is initiated. With appropriate antibiotic therapy, many patients experience significant improvement. However, the disease can be life-threatening, especially if it spreads to the brain or if the patient has a compromised immune system.

Nocardiosis is caused by bacteria from the genus Nocardia, which are aerobic actinomycetes. These bacteria are found worldwide in soil, decaying vegetation, and water. Humans typically acquire the infection through inhalation of contaminated dust or through direct skin contact with contaminated materials.

Nocardiosis is considered an uncommon disease, with an estimated incidence of 500 to 1,000 cases per year in the United States. It is more prevalent in tropical and subtropical regions. The disease is more frequently observed in individuals with weakened immune systems, such as those with HIV/AIDS, cancer, or organ transplants, but it can also affect healthy individuals.

Nocardia bacteria are opportunistic pathogens, meaning they take advantage of weakened immune defenses to cause disease. Once inhaled or introduced through the skin, the bacteria can evade the immune system and establish infection. In the lungs, they can cause inflammation and tissue damage, leading to symptoms similar to pneumonia. If the bacteria spread through the bloodstream, they can infect other organs, such as the brain or skin.

Preventing nocardiosis involves minimizing exposure to Nocardia bacteria, especially for individuals with weakened immune systems. This can include wearing protective clothing and masks when working with soil or decaying organic matter. Maintaining good hygiene and promptly treating any skin injuries can also help reduce the risk of infection.

Nocardiosis is a rare but serious infection caused by Nocardia bacteria, primarily affecting the lungs but capable of spreading to other organs. It presents with symptoms similar to pneumonia and requires long-term antibiotic treatment. The disease is more common in individuals with weakened immune systems, but it can also occur in healthy people. Early diagnosis and treatment are crucial for a favorable outcome.

If you suspect you have symptoms of nocardiosis, such as a persistent cough, chest pain, or unexplained skin lesions, it is important to seek medical evaluation. Diagnosis involves specific tests to identify the presence of Nocardia bacteria. Treatment typically includes antibiotics for an extended period. While the disease can be serious, especially if it spreads to the brain, many patients respond well to treatment with timely medical intervention.

1. Yamagata M, Hirose K, Ikeda K, and Nakajima H. Clinical Characteristics of Nocardia Infection in Patients with Rheumatic Diseases. Clinical and Developmental Immunology. 2013 ID 818654: 4 pages.
2. Aggarwal D, Garg K, Chander J, Saini V, Janmeja AK. Pulmonary nocardiosis revisited: A case series. Lung India : Official Organ of Indian Chest Society. 2015;32(2):165-168.
3. Wilson JW. Nocardiosis: Updates and Clinical Overview. Mayo Clin Proc. 2012 Apr; 87(4): 403–407.
4. Brown-Elliott B.A., Brown J.M., Conville P.S., Wallace R.J., Jr. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev. 2006;19(2):259–282.
5. Chedid MBF, Chedid MF, Porto NS, Severo SB, Severo LC. Nocardial infections: report of 22 cases. Rev. Inst. Med. Trop. S. Paulo. 2007 Jul-Aug; 49 (4).
6. Blackmon KN, Ravenel JG, Gomez JM, Ciolino J, Wray DW. Pulmonary nocardiosis: computed tomography features at diagnosis. J Thorac Imaging. 2011; 26: 224–229.
7. Chen J, Zhou H, Xu P, Zhang P, Ma S, Zhou J. Clinical and Radiographic Characteristics of Pulmonary Nocardiosis: Clues to Earlier Diagnosis. PLoS ONE. 2014; 9(3): e90724.
8. Zheng Y, Wang T, Hsu J, et al. Clinical Pathway in the Treatment of Nocardial Brain Abscesses following Systemic Infections. Case Reports in Neurological Medicine. 2014; Article ID 584934.